Ulcerative Colitis Clinical Trials in New York

Showing 521-540 of 767 trials

Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)

NCT01875874

This phase 2 study is developed to evaluate the effect of ELAD on overall survival (OS) in subjects with acute liver failure (ALF) compared to matched historical controls.

Acute Liver FailureFulminant Hepatic FailurePrimary Graft Non-Function+1 more

Vital Therapies, Inc.8 participantsStarted Oct 2014

Los Angeles, California, United States • Washington D.C., District of Columbia, United States • Miami, Florida, United States +15 more locations

COMPLETED< 1 mile

Fecal Calprotectin Collection Protocol

NCT03143517

The primary objective is to obtain stool samples from subjects diagnosed with , and displaying signs and/or symptoms of IBD and/or IBS will be evaluated in this study. Eligible subjects require a diagnostic colonoscopy with possible biopsy and clinical evaluation.

Inflammatory Bowel DiseasesIrritable Bowel SyndromeUlcerative Colitis+10 more

DiaSorin Inc.240 participantsStarted Apr 2017

Dothan, Alabama, United States • Little Rock, Arkansas, United States • Mission Hills, California, United States +10 more locations

Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)

Fecal Calprotectin Collection Protocol

Ulcerative Colitis Trials in Other Cities

Mechanisms of Endothelial Cell Dysfunction in Sleep Apnea

Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer

Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus

Nilotinib in TKI Resistant or Intolerant Patients With Metastatic Mucosal, Acral, or Chronically Sun Damaged Melanoma

Intraocular Pressure Fluctuation in Patients With Glaucoma and in Healthy Patients During Standard Yoga Positions

A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Plant Cell Expressed Recombinant Human Glucocerebrosidase Extension Trial

Switchover Trial From Imiglucerase to Plant Cell Expressed Recombinant Human Glucocerebrosidase

Adherence Study in COPD Patients

Summative Usability Study of Ciprofloxacin Dry Powder for Inhalation Using Placebo

A 24-week Evaluation of GSK573719/Vilanterol (62.5/25mcg) and Components in COPD

Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD

A Study of Oral AT2101 (Afegostat Tartrate) in Treatment-naive Patients With Gaucher Disease

A Long-Term Extension Study of AT2101 (Afegostat Tartrate) in Type 1 Gaucher Patients

Effect of Aclidinium/Formoterol on Lung Hyperinflation, Exercise Capacity and Physical Activity in Moderate to Severe COPD Patients

Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks

A Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)

Safety and Dose Ranging Study of Insulin Receptor MoAb-IDS Fusion Protein in Patients With Hunter Syndrome

Other Conditions in New York